Login
Home
Charts
Search
Watchlist
Products

Sotac Pharmaceuticals Ltd

SOTAC·NSE
₹90.050.00%Wed, 23 Sept '26
Industry:Pharmaceuticals Bulk Drugs & Formulation
Indices:

Sotac Pharmaceuticals Ltd

SOTAC
NSE
₹90.05
0.00%
|Wed, 23 Sept '26
SOICxStockScans Reports
Industry
Pharmaceuticals Bulk Drugs & Formulation
Indices
View
Financials
Documents
Shareholdings
Corporate Actions
Segments
Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Peer Comparison
Financials
Documents
Shareholdings
Corporate Actions
Segments
Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Peer Comparison
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹100Cr
Close
Close Price
₹90.05
Industry
Industry
Pharmaceuticals Bulk Drugs & Formulation
PE
Price To Earnings
17.25
PS
Price To Sales
0.98
Revenue
Revenue
₹101Cr
Rev Gr TTM
Revenue Growth TTM
1.51%
PAT Gr TTM
PAT Growth TTM
-32.22%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterJun 2022Sep 2022Mar 2023Sep 2023Mar 2024Sep 2024Mar 2025Sep 2025Mar 2026
Revenue
RevenueCr
204038525253473760
Growth YoY
Revenue Growth YoY%
29.938.31.8-9.7-29.627.4
Expenses
ExpensesCr
183634474848353350
Operating Profit
Operating ProfitCr
13444412410
OPM
OPM%
7.38.610.28.67.48.225.69.816.8
Other Income
Other IncomeCr
010001040
Interest Expense
Interest ExpenseCr
011111222
Depreciation
DepreciationCr
111121233
PBT
PBTCr
1334341168
Tax
TaxCr
011111111
PAT
PATCr
011122834
Growth YoY
PAT Growth YoY%
17.687.447.5215.646.3-50.7
NPM
NPM%
1.22.63.42.34.63.415.97.06.2
EPS
EPS₹
0.00.00.01.62.31.75.52.23.0
QuarterJun 2022Sep 2022Mar 2023Sep 2023Mar 2024Sep 2024Mar 2025Sep 2025Mar 2026
Revenue
RevenueCr
204038525253473760
Growth YoY
Revenue Growth YoY%
29.938.31.8-9.7-29.627.4
Expenses
ExpensesCr
183634474848353350
Operating Profit
Operating ProfitCr
13444412410
OPM
OPM%
7.38.610.28.67.48.225.69.816.8
Other Income
Other IncomeCr
010001040
Interest Expense
Interest ExpenseCr
011111222
Depreciation
DepreciationCr
111121233
PBT
PBTCr
1334341168
Tax
TaxCr
011111111
PAT
PATCr
011122834
Growth YoY
PAT Growth YoY%
17.687.447.5215.646.3-50.7
NPM
NPM%
1.22.63.42.34.63.415.97.06.2
EPS
EPS₹
0.00.00.01.62.31.75.52.23.0

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2020Mar 2021Mar 2023Mar 2024Mar 2025Mar 2026
Revenue
RevenueCr
29497710497101
Growth
Revenue Growth%
70.834.0-6.64.4
Expenses
ExpensesCr
274770958383
Operating Profit
Operating ProfitCr
21791418
OPM
OPM%
6.53.09.48.214.117.7
Other Income
Other IncomeCr
000040
Interest Expense
Interest ExpenseCr
012234
Depreciation
DepreciationCr
132345
PBT
PBTCr
0-244119
Tax
TaxCr
002022
PAT
PATCr
0-22496
Growth
PAT Growth%
-2,803.356.6159.1-32.2
NPM
NPM%
0.3-4.83.03.59.66.2
EPS
EPS₹
0.9-10.33.63.97.35.2
Financial YearMar 2020Mar 2021Mar 2023Mar 2024Mar 2025Mar 2026
Revenue
RevenueCr
29497710497101
Growth
Revenue Growth%
70.834.0-6.64.4
Expenses
ExpensesCr
274770958383
Operating Profit
Operating ProfitCr
21791418
OPM
OPM%
6.53.09.48.214.117.7
Other Income
Other IncomeCr
000040
Interest Expense
Interest ExpenseCr
012234
Depreciation
DepreciationCr
132345
PBT
PBTCr
0-244119
Tax
TaxCr
002022
PAT
PATCr
0-22496
Growth
PAT Growth%
-2,803.356.6159.1-32.2
NPM
NPM%
0.3-4.83.03.59.66.2
EPS
EPS₹
0.9-10.33.63.97.35.2

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2020Mar 2021Mar 2023Mar 2024Mar 2025
Equity Capital
Equity CapitalCr
2281111
Reserves
ReservesCr
1023442
Current Liabilities
Current LiabilitiesCr
1923464452
Non Current Liabilities
Non Current LiabilitiesCr
6981214
Total Liabilities
Total LiabilitiesCr
303574105124
Current Assets
Current AssetsCr
1417476170
Non Current Assets
Non Current AssetsCr
1717274555
Total Assets
Total AssetsCr
303574105124
Financial YearMar 2020Mar 2021Mar 2023Mar 2024Mar 2025
Equity Capital
Equity CapitalCr
2281111
Reserves
ReservesCr
1023442
Current Liabilities
Current LiabilitiesCr
1923464452
Non Current Liabilities
Non Current LiabilitiesCr
6981214
Total Liabilities
Total LiabilitiesCr
303574105124
Current Assets
Current AssetsCr
1417476170
Non Current Assets
Non Current AssetsCr
1717274555
Total Assets
Total AssetsCr
303574105124

Cash Flow

Consolidated
Standalone
Financial YearMar 2020Mar 2021Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
008-16-417
Investing Cash Flow
Investing Cash FlowCr
-12-3-12-20-14-7
Financing Cash Flow
Financing Cash FlowCr
113132916-10
Net Cash Flow
Net Cash FlowCr
0010-6-20
Free Cash Flow
Free Cash FlowCr
-10-30-29-21
CFO To PAT
CFO To PAT%
65.113.0356.2-449.1-46.7268.2
CFO To EBITDA
CFO To EBITDA%
3.1-21.1112.3-188.8-31.894.3
Financial YearMar 2020Mar 2021Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
008-16-417
Investing Cash Flow
Investing Cash FlowCr
-12-3-12-20-14-7
Financing Cash Flow
Financing Cash FlowCr
113132916-10
Net Cash Flow
Net Cash FlowCr
0010-6-20
Free Cash Flow
Free Cash FlowCr
-10-30-29-21
CFO To PAT
CFO To PAT%
65.113.0356.2-449.1-46.7268.2
CFO To EBITDA
CFO To EBITDA%
3.1-21.1112.3-188.8-31.894.3

Ratios

Consolidated
Standalone
Financial YearMar 2020Mar 2021Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
134131121100
Price To Earnings
Price To Earnings
31.316.420.917.3
Price To Sales
Price To Sales
1.31.41.21.0
Price To Book
Price To Book
3.02.52.01.7
EV To EBITDA
EV To EBITDA
18.212.77.6
Profitability Ratios
Profitability Ratios
GPM
GPM%
19.814.519.215.121.5
OPM
OPM%
6.53.09.48.214.117.717.7
NPM
NPM%
0.3-4.83.03.59.66.26.2
ROCE
ROCE%
4.2-5.318.48.114.1
ROE
ROE%
2.9-94.922.97.917.4
ROA
ROA%
0.3-6.83.13.47.5
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2020Mar 2021Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
134131121100
Price To Earnings
Price To Earnings
31.316.420.917.3
Price To Sales
Price To Sales
1.31.41.21.0
Price To Book
Price To Book
3.02.52.01.7
EV To EBITDA
EV To EBITDA
18.212.77.6
Profitability Ratios
Profitability Ratios
GPM
GPM%
19.814.519.215.121.5
OPM
OPM%
6.53.09.48.214.117.717.7
NPM
NPM%
0.3-4.83.03.59.66.26.2
ROCE
ROCE%
4.2-5.318.48.114.1
ROE
ROE%
2.9-94.922.97.917.4
ROA
ROA%
0.3-6.83.13.47.5
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios

Documents — Sotac Pharmaceuticals Ltd

  • Q4 FY2026 Quarterly Result (Mar 2026, PDF): https://www.stockscans.in/document/tdx7xucs6wzy3ds5fnflrter.pdf
  • Q2 FY2026 Quarterly Result (Sep 2025, PDF): https://www.stockscans.in/document/86hpnf29g3u4qli5hwn8wzcz.pdf
  • Q4 FY2025 Quarterly Result (Mar 2025, PDF): https://www.stockscans.in/document/m3w4snik25curfopj1o10etm.pdf
  • Q2 FY2025 Quarterly Result (Sep 2024, PDF): https://www.stockscans.in/document/uhv5421zpau6x4vrp43i5uoh.pdf
  • Q1 FY2025 Quarterly Result (Jun 2024, PDF): https://www.stockscans.in/document/el9sy2auly8g970w1xey0kn4.pdf
  • Q4 FY2024 Quarterly Result (Mar 2024, PDF): https://www.stockscans.in/document/hedl3fleyv330sjwh8umk6jz.pdf
  • FY2025 Annual Report (PDF): https://www.stockscans.in/document/rhs9xtkhx6tzh3pff1g1ji41.pdf
  • FY2024 Annual Report (PDF): https://www.stockscans.in/document/qkzl1ask3z7boi4zy5vmjna5.pdf
  • FY2023 Annual Report (PDF): https://www.stockscans.in/document/bknfu5dw53hrekgpb1kglhnj.pdf

Simplify stock analysis with powerful tools and clear insights for confident, data-driven decisions.

support@stockscans.in
© StockScans by SOIC Technologies Pvt Ltd
349 A, Lodhi Road, Punjabi Bazar, New DelhiData provided by CMOTS Internet Technologies